These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21935653)

  • 1. Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.
    Modell V; Gee B; Lewis DB; Orange JS; Roifman CM; Routes JM; Sorensen RU; Notarangelo LD; Modell F
    Immunol Res; 2011 Oct; 51(1):61-70. PubMed ID: 21935653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network.
    Quinn J; Modell V; Orange JS; Modell F
    Allergy Asthma Clin Immunol; 2022 Mar; 18(1):19. PubMed ID: 35246253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes.
    Modell V; Orange JS; Quinn J; Modell F
    Immunol Res; 2018 Jun; 66(3):367-380. PubMed ID: 29744770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network.
    Modell V; Quinn J; Orange J; Notarangelo LD; Modell F
    Immunol Res; 2016 Jun; 64(3):736-53. PubMed ID: 26802037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jeffrey's insights: Jeffrey Modell Foundation's global genetic sequencing pilot program to identify specific primary immunodeficiency defects to optimize disease management and treatment.
    Quinn J; Modell V; Holle J; Truty R; Aradhya S; Johnson B; Orange J; Modell F
    Immunol Res; 2020 Jun; 68(3):126-134. PubMed ID: 32462469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling strategy to identify patients with primary immunodeficiency utilizing risk management and outcome measurement.
    Modell V; Quinn J; Ginsberg G; Gladue R; Orange J; Modell F
    Immunol Res; 2017 Jun; 65(3):713-720. PubMed ID: 28224361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery.
    Modell V; Knaus M; Modell F; Roifman C; Orange J; Notarangelo LD
    Immunol Res; 2014 Oct; 60(1):132-44. PubMed ID: 24668296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Expansion of Jeffrey's Insights: Jeffrey Modell Foundation's Genetic Sequencing Program for Primary Immunodeficiency.
    Quinn J; Modell V; Johnson B; Poll S; Aradhya S; Orange JS; Modell F
    Front Immunol; 2022; 13():906540. PubMed ID: 35757720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From genotype to phenotype. Further studies measuring the impact of a Physician Education and Public Awareness Campaign on early diagnosis and management of primary immunodeficiencies.
    Modell F; Puente D; Modell V
    Immunol Res; 2009; 44(1-3):132-49. PubMed ID: 19140027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of common variable immunodeficiency: annual cost of disease.
    Sadeghi B; Abolhassani H; Naseri A; Rezaei N; Aghamohammadi A
    Expert Rev Clin Immunol; 2015 May; 11(5):681-8. PubMed ID: 25804338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary immunodeficiency diseases worldwide: more common than generally thought.
    Bousfiha AA; Jeddane L; Ailal F; Benhsaien I; Mahlaoui N; Casanova JL; Abel L
    J Clin Immunol; 2013 Jan; 33(1):1-7. PubMed ID: 22847546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health care and infective aspects in patients affected by common variable immunodeficiency assisted in the Lazio Regional Authority Reference Centre for Primary Immunodeficiencies].
    De Santis W; Esposito A; Conti V; Fantauzzi A; Guerra A; Mezzaroma I; Aiuti F
    Infez Med; 2006 Mar; 14(1):13-23. PubMed ID: 16794375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary immunodeficiencies in Central and Eastern Europe-the power of networking Report on the activity of the Jeffrey Modell Foundation Centers Network in Central and Eastern Europe.
    Sediva A; Bataneant M; Belevtsev M; Blaziene A; Ciznar P; Förster-Waldl E; Kelecic J; Marodi J; Naumova E; Nasrullayeva G; Ress K; Serban M; Sitkauskiene B; Toth B; Modell V; Modell F; Tenembaum V; Marković M; Avcin T
    Immunol Res; 2019 Oct; 67(4-5):358-367. PubMed ID: 31515711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalences [correction] and patient characteristics of primary immunodeficiency diseases in Turkey--two centers study.
    Kilic SS; Ozel M; Hafizoglu D; Karaca NE; Aksu G; Kutukculer N
    J Clin Immunol; 2013 Jan; 33(1):74-83. PubMed ID: 22983506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common Variable Immunodeficiency and Autoimmune Diseases: A Retrospective Study of 95 Adult Patients in a Single Tertiary Care Center.
    Mormile I; Punziano A; Riolo CA; Granata F; Williams M; de Paulis A; Spadaro G; Rossi FW
    Front Immunol; 2021; 12():652487. PubMed ID: 34290696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shorter Diagnostic Delay in Polish Adult Patients With Common Variable Immunodeficiency and Symptom Onset After 1999.
    Ziętkiewicz M; Więsik-Szewczyk E; Matyja-Bednarczyk A; Napiórkowska-Baran K; Zdrojewski Z; Jahnz-Różyk K
    Front Immunol; 2020; 11():982. PubMed ID: 32655544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common variable immunodeficiency.
    Abonia JP; Castells MC
    Allergy Asthma Proc; 2002; 23(1):53-7. PubMed ID: 11894736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for severe combined immunodeficiency (SCID) and T cell lymphopenia newborn screening: saving lives…one at a time.
    Quinn J; Orange JS; Modell V; Modell F
    Immunol Res; 2020 Feb; 68(1):48-53. PubMed ID: 32128663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Characterization of a Nationwide Danish Adult Common Variable Immunodeficiency Cohort.
    Westh L; Mogensen TH; Dalgaard LS; Bernth Jensen JM; Katzenstein T; Hansen AE; Larsen OD; Terpling S; Nielsen TL; Larsen CS
    Scand J Immunol; 2017 Jun; 85(6):450-461. PubMed ID: 28370285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common Variable Immunodeficiency: Epidemiology, Pathogenesis, Clinical Manifestations, Diagnosis, Classification, and Management.
    Yazdani R; Habibi S; Sharifi L; Azizi G; Abolhassani H; Olbrich P; Aghamohammadi A
    J Investig Allergol Clin Immunol; 2020; 30(1):14-34. PubMed ID: 30741636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.